source
- Massachusetts biotech sees record-first-half VC funding and IPO surge despite modest NIH funding dipThe latest MassBio Industry Snapshot reports a strong start to 2026 for the state’s biotech sector, with venture capital inflows rising 25% year over year to $3.45 billion in the first half of the…
- DC judge dismisses Merck's challenge to Medicare drug price negotiationsA Washington D.C. federal judge rejected Merck's lawsuit contesting Medicare drug price negotiations under the Inflation Reduction Act. Judge Colleen Kollar-Kotelly of the U.S. District Court for t…